Reaction to data shared by Moderna on its bivalent Omicron vaccine
In a press release published this week, Moderna has shared the first data on its new bivalent adapted vaccine against Omicron.
In a press release published this week, Moderna has shared the first data on its new bivalent adapted vaccine against Omicron.
A paper published today in the journal Circulation concludes that acute myocarditis is a rare complication in patients hospitalised with covid-19 and that the severity of its prognosis depends on the simultaneous presence of pneumonia.
The European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) consider it too early for the general population to receive a fourth dose of covid-19 mRNA vaccines. Both agencies do agree that people over 80 years of age should receive it because of their increased risk of severe disease.
Two studies published in The Lancet Infectious Diseases confirm that covid-19 vaccines offer additional protection for those already infected with SARS-CoV-2, especially against severe disease.
Reporting on vaccines is not easy, but in recent years many journalists have had to navigate studies and reports full of new terminology and concepts. In this guide, we attempt to clarify some of the most important points for accurate reporting on these medicines.
More than two million doses of the vaccine from US company Novavax are expected to arrive in Spain soon. Nuvaxovid, or NVX-CoV2373, became the fifth vaccine approved in Europe against covid-19 on 20 December. We tell you how it differs from those already available, how it is produced and why it is especially important for countries with fewer resources.
Several results confirm that vaccination against covid-19 does not affect fertility. One of them, carried out on some 2,000 couples and published in the American Journal of Epidemiology, compares the ability to conceive naturally in vaccinated and unvaccinated couples. The other, in Obstetrics & Gynecology, studies some 1,300 vaccinated and unvaccinated women who have used different assisted reproductive techniques. Neither paper finds a link between vaccination and pregnancy.
In Spain, since 13 January, the booster vaccination against covid-19 has been recommended for the general adult population. 78.8 % of those over 50 and 88.9 % of those over 60 have already had it, said the Minister of Health yesterday. If those who are missing have doubts, here we try to solve them.
Spain recommends that people who have been infected with the coronavirus receive the third dose four weeks later. Experts assess the decision from an immunological point of view.
The director of the Vaccine Strategy of the European Medicines Agency (EMA), Marco Cavaleri, told a press conference on 11 January that "it is not sustainable in the long term to continue giving booster doses every three or four months [to the general population]". Spanish immunologists agree that this is not the right thing to do. In these reactions they explain why.